Paper Title
A review on Pharmacological and Phytochemical properties of Luffa echinata
Article Identifiers
Authors
Sonal H. Kanani , Dr. Devang J Pandya
Keywords
Devadali, Cytotoxic, Cucurbitacine, Cucurbitaceae, TNBC, Pharmacological
Abstract
Background: Plants are the source of a variety of important secondary metabolites with pharmacological and pharmacognostic consequences that have the potential to become future "super medicines." The biotic and abiotic stressors have an impact on how these metabolites are produced in vivo, which causes a steady build-up of different phytochemicals. and their derivatives, which can help create and develop future medications. The current study's goal is to review the occurrence of potentially useful pharmacological and pharmacognostic secondary metabolites considering the possible uses of the understudied Ayurvedic medicinal plant species Luffa echinata inventing and creating pharmaceuticals for the future. Main body of the abstract: Luffa echinata, a member of the Cucurbitaceae family, is a rich source of phytochemicals for therapeutic use, including Cucurbitacine B, Cucurbitacine E, Eletarin-2-glycoside, Beta-sterol glycoside, Chrysirol, Echinatin, Apigenin, Luteolin, Luteolin-7-glycoside, Datiscacin, Oleanolic acid. These substances all or some of which have anti-cancer, antioxidant, antimicrobial, antibacterial, antiviral, analgesic, anti-inflammatory, antidepressant, anxiolytic, antiepileptic, hepatoprotective, antifungal, and antiulcer activity. Short Conclusion: alkaloids, carbohydrates, proteins, glycosides, flavonoids, sterols, triterpenes, flavones, reducing sugars, and tannins. Potent bioactive compounds like CuB, eletarin (CuE), eletarin-2-glucoside, isocucurbitacin B, β-sitosterol, echinatol-A, and -B, chrysirol-7-glucoside, chrysirol-7-epiglucoside, echinatol A, echinatol B, echinatin have been reported from the fruits. Datiscacin (cucurbitin-20-acetate) found in Luffa echinata that have the potential to replace conventional drugs as therapeutic agents. Its uses may be attributed to important classes of phytochemicals present in it; a bitter compound known to have antitumor activity has been reported from L. echinata. Similarly, flavonoids (luteolin-7-glucoside and chrysoeriol-7-glucoside), triterpenes, fatty acids, and saponin (gypsogennin) have been also isolated from seeds. The present chapter gives a detailed review of Luffa echinata chiefly from its pharmacognostic, phytochemical, and utility perspectives.
Downloads
How To Cite (APA)
Sonal H. Kanani & Dr. Devang J Pandya (March-2023). A review on Pharmacological and Phytochemical properties of Luffa echinata . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 8(3), a1-a11. https://ijnrd.org/papers/IJNRD2303001.pdf
Issue
Volume 8 Issue 3, March-2023
Pages : a1-a11
Other Publication Details
Paper Reg. ID: IJNRD_184734
Published Paper Id: IJNRD2303001
Downloads: 000121199
Research Area: Pharmacy
Country: Rajkot, GUJARAT, INDIA
Published Paper PDF: https://ijnrd.org/papers/IJNRD2303001.pdf
Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRD2303001
About Publisher
Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)
ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition
Publication Timeline
Article Preview: View Full Paper
Call For Paper
IJNRD is a Scholarly Open Access, Peer-reviewed, and Refereed Journal with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost Journal that follows UGC CARE 2025 Peer-Reviewed Journal Policy norms, Scopus journal standards, and Transparent Peer Review practices to ensure quality and credibility. IJNRD provides indexing in all major databases & metadata repositories, a citation generator, and Digital Object Identifier (DOI) for every published article with full open-access visibility.
The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse fields. Its goal is to promote global scientific information exchange among researchers, developers, engineers, academicians, and practitioners. IJNRD serves as a platform where educators and professionals can share research evidence, models of best practice, and innovative ideas, contributing to academic growth and industry relevance.
Indexing Coverage includes Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many more recognized academic repositories.
How to submit the paper?
By Our website
Click Here to Submit Paper Online
Important Dates for Current issue
Paper Submission Open For: September 2025
Current Issue: Volume 10 | Issue 9 | September 2025
Impact Factor: 8.76
Last Date for Paper Submission: Till 30-Sep-2025
Notification of Review Result: Within 1-2 Days after Submitting paper.
Publication of Paper: Within 01-02 Days after Submititng documents.
Frequency: Monthly (12 issue Annually).
Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.
Subject Category: Research Area
Call for Paper: More Details
